Kobayashi Pharmaceutical Co., Ltd. (TYO:4967)

Kobayashi Pharmaceutical Revenue

Kobayashi Pharmaceutical had revenue of 35.38B JPY in the quarter ending June 30, 2026, a decrease of -2.85%. This brings the company's revenue in the last twelve months to 167.47B, up 3.71% year-over-year. In the year 2025, Kobayashi Pharmaceutical had annual revenue of 165.74B with 0.09% growth.

• Revenue (ttm): 167.47B
• Revenue Growth: +3.71%
• P/S Ratio: 2.50
• Revenue / Employee: 44.89M
• Employees: 3,731
• Market Cap: 418.82B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	165.74B	142.00M	0.09%
Dec 31, 2024	165.60B	-7.86B	-4.53%
Dec 31, 2023	173.46B	7.20B	4.33%
Dec 31, 2022	166.26B	11.01B	7.09%
Dec 31, 2021	155.25B	4.74B	3.15%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 18, 2026

Data Sources Report a data error